Roth Capital Has Pessimistic View of FIGS FY2026 Earnings

FIGS, Inc. (NYSE:FIGS) – Analysts at Roth Capital reduced their FY2026 earnings estimates for shares of FIGS in a research report issued to clients and investors on Wednesday, August 6th. Roth Capital analyst M. Koranda now anticipates that the company will post earnings of $0.11 per share for the year, down from their previous estimate of $0.12. The consensus estimate for FIGS’s current full-year earnings is $0.01 per share.

FIGS (NYSE:FIGS) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.02. The company had revenue of $152.64 million for the quarter, compared to analyst estimates of $144.17 million. FIGS had a net margin of 1.26% and a return on equity of 1.85%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.01 earnings per share.

Other equities analysts also recently issued reports about the company. Cowen reissued a “hold” rating on shares of FIGS in a research report on Friday. Barclays reissued a “positive” rating on shares of FIGS in a research report on Tuesday, May 13th. Wall Street Zen raised FIGS from a “hold” rating to a “strong-buy” rating in a research report on Saturday. Telsey Advisory Group reissued a “market perform” rating and set a $7.00 price objective (up from $5.00) on shares of FIGS in a research report on Monday, August 4th. Finally, Morgan Stanley boosted their price objective on FIGS from $4.25 to $5.00 and gave the stock an “equal weight” rating in a research report on Monday, July 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, FIGS currently has a consensus rating of “Hold” and an average price target of $5.38.

FIGS Stock Performance

Shares of FIGS stock opened at $6.24 on Friday. FIGS has a one year low of $3.57 and a one year high of $7.05. The company has a market cap of $1.01 billion, a PE ratio of 156.04 and a beta of 1.34. The business has a 50-day simple moving average of $5.78 and a 200-day simple moving average of $5.08.

Hedge Funds Weigh In On FIGS

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its holdings in shares of FIGS by 12,795.0% in the second quarter. Farther Finance Advisors LLC now owns 5,158 shares of the company’s stock valued at $29,000 after acquiring an additional 5,118 shares during the period. GAMMA Investing LLC boosted its holdings in shares of FIGS by 585.8% in the first quarter. GAMMA Investing LLC now owns 6,536 shares of the company’s stock valued at $30,000 after acquiring an additional 5,583 shares during the period. Capstone Financial Advisors Inc. acquired a new stake in shares of FIGS in the second quarter valued at approximately $56,000. Teacher Retirement System of Texas acquired a new stake in shares of FIGS in the first quarter valued at approximately $66,000. Finally, Stifel Financial Corp acquired a new stake in shares of FIGS in the fourth quarter valued at approximately $70,000. 92.21% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at FIGS

In related news, CFO Sarah Oughtred sold 99,834 shares of the company’s stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $6.19, for a total value of $617,972.46. Following the completion of the transaction, the chief financial officer directly owned 878,058 shares of the company’s stock, valued at $5,435,179.02. This represents a 10.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 22.30% of the stock is owned by company insiders.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.